Wednesday, 16 August 2017

Generics News

  • India: PSUs need to be revived to boost generics

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 20 Aug, 2013

    Singapore: Raising concerns related to the fate of people who cannot afford expensive branded medicines, India's parliamentary committee has made suggestions that would help boost generic d...Read more

  • Debate over compulsory licensing of Bayer's Nexavar

    Generics |  Regulatory | By BioSpectrum Bureau | 0 Comment | 30 Apr, 2012

    Thecase of Indian pharma company's request for a compulsory license to make a generic version of Bayer's patented drug to treat liver and kidney cancer was settled on March 13, 2012. In a f...Read more

  • British drug major GSK awaits Chinese probe details

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 05 Jul, 2013

    Singapore: Even six days after Chinese police detailed some senior executives working at the Chinese office of the biggest British drugmaker, GlaxoSmithKline, the company has no information...Read more

  • Glenmark-MSD patent suit put on hold by Indian HC

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 02 Aug, 2013

    Singapore: In what looked like a patent suit that could stir further controversy about patenting in the life sciences industry, US drug major Merck Sharp and Dohme (MSD) filed a patent agai...Read more

  • Aged society fuels growth of generics

    Generics |  Analysis | By Narayan Kulkarni | 0 Comment | 01 Jun, 2012

    A rapidly aging population has burdened the healthcare system both in terms of funding and facilities and is of great concern for the Japanese government. To ease spending on healthcare, th...Read more

  • GSK China VP confesses in bribery scandal

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 18 Jul, 2013

    Singapore: A day after Chinese police made the names of those involved in one of the country's biggest scandal involving a major pharmaceutical company public, GlaxoSmithKline China's vice ...Read more

  • India revokes Roche's cancer drug Herceptin patent

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 05 Aug, 2013

    New Delhi: In what is being criticized as yet another miserable experience created by India's intellectual property and pricing authorities for western drugmakers, the country has partly re...Read more

  • DCGI asks Wockhardt, Ranbaxy to explain lapses

    Generics |  Regulatory | By BioSpectrum Bureau | 0 Comment | 02 Sep, 2013

    Singapore: The Indian Drug Controller General of India (DCGI) has written a letter to the drug maker Wockhardt to explain the deficiencies found at its Aurangabad manufacturing unit. The FD...Read more

  • Dr. Reddy's launches generic psychiatric drug

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 23 Aug, 2013

    Singapore: Dr. Reddy's Laboratories has launched drug for psychiatric conditions, Divalproex Sodium extended release tablets (250 mg and 500 mg). These are therapeutic equivalent generic v...Read more

  • Strides gets tentative FDA nod for HIV generic

    Generics |  Regulatory | By BioSpectrum Bureau | 0 Comment | 02 Aug, 2013

    Singapore: FDA has granted tentative approval to India-based Strides Arcolab's HIV drug emtricitabine and tenofovir disoproxil fumarate tablets, 200 mg/300 mg. The drug is a generic versio...Read more

  • GSK hit by more bribery allegations in China

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 08 Jul, 2013

    Singapore: Days after a probe was initiated by the Chinese police into alleged 'economic crimes' committed by senior officials of GlaxoSmithKline in China, a latest news report has now rele...Read more

  • Ranbaxy launches generic of Pioglitazone in US

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 20 Aug, 2012

    Bangalore: Ranbaxy Pharmaceuticals, a wholly owned subsidiary of Ranbaxy Laboratories, has launched authorized generic pioglitazone hydrochloride tablets in the US market, under an agreeme...Read more

  • Abbott rejigs strategy, realigns India business

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 12 Jul, 2013

    Singapore: After acquiring the formulations business of India's Piramal Healthcare in 2010, US drug major Abbott Laboratories has now revealed its new growth strategy. In an effort to boost...Read more

  • Chinese medicine firm Tianyin gets GMP certificate

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 16 Sep, 2013

    Singapore: China-based Tianyin Pharmaceutical (TPI) received GMP certification for its pre-extraction plant and formulate facilities. Tianyin Pharmaceutical is a pharmaceutical company th...Read more

  • Natco wins patent dispute case against Teva

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 04 Mar, 2014

    Singapore: Based in India's Hyderabad, drug manufacturing major Natco Pharmaceuticals has won a long standing patent dispute case against Israeli drug major Teva Pharmaceuticals. The High ...Read more

  • Lilly to expand generics manufacturing facility in China

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 06 Mar, 2014

    Singapore: Lilly and Novast Laboratories have commenced the expansion of manufacturing and development facility capacities in Nantong, Jiangsu, China. The expansion is a result of Lilly's s...Read more

  • Ranbaxy to market infliximab biosimilar

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 09 Jan, 2014

    Singapore: Switzerland based EPIRUS, a wholly-owned subsidiary of Boston-based EPIRUS Biopharmaceuticals, and Ranbaxy Laboratories, a division of Daiichi Sankyo Company, Tokyo, have signed ...Read more

  • US FDA issues API bulk & tapped density guidance

    Generics |  Regulatory | By BioSpectrum Bureau | 0 Comment | 11 Jul, 2013

    Singapore: The US Food and Drug Administration (FDA) has issued guidance to the Active Pharmaceutical ingredient industry on bulk density and tapped density of powders. The norms revolve a...Read more

Survey Box

Does Asia have more to offer to the global 3D cell culture market?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls